Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

333.20DKK
22 May 2013
Price Change (% chg)

kr.4.50 (+1.37%)
Prev Close
kr.328.70
Open
kr.328.70
Day's High
kr.333.70
Day's Low
kr.327.50
Volume
336,661
Avg. Vol
494,850
52-wk High
kr.334.50
52-wk Low
kr.197.10

COLOb.CO

Chart for COLOb.CO

About

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care products for people... (more)

Overall

Beta: 0.22
Market Cap (Mil.): kr.66,397.40
Shares Outstanding (Mil.): 202.00
Dividend: 3.00
Yield (%): 1.52

Financials

  COLOb.CO Industry Sector
P/E (TTM): 28.52 30.14 35.13
EPS (TTM): 11.53 -- --
ROI: 34.11 10.40 18.83
ROE: 43.36 13.41 19.68
Search Stocks

UPDATE 1-Denmark's Coloplast to pay special dividend, shares jump

COPENHAGEN, April 30 - Shares in Danish healthcare product maker Coloplast jumped almost 5 percent on Tuesday after it announced a one-off dividend, rewarding shareholders after quarterly earnings grew in all of its business units.

30 Apr 2013

Coloplast sticks to year forecast despite miss on Q2 profits

COPENHAGEN, April 30 - Danish healthcare products maker Coloplast stood by its outlook for the full year after second quarter operating profits rose 12 percent, missing forecasts.

30 Apr 2013

Coloplast cuts sales forecast on currency swings

COPENHAGEN - Danish healthcare product maker Coloplast cut its full-year Danish-crown sales forecast on Wednesday due to unfavorable currency developments, after reporting first-quarter results roughly in line with forecasts.

30 Jan 2013

UPDATE 1-Coloplast cuts sales forecast on currency swings

* Keeps FY outlook unchanged in local currencies, cuts in DKK

30 Jan 2013

Coloplast Q1 EBIT narrowly beats forecasts

COPENHAGEN, Jan 30 - Danish healthcare products maker Coloplast on Wednesday reported first-quarter operating profits just above expectations.

30 Jan 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
$250.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks